参考文献/References:
[1]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,6(4):67-80.
[2]刘娅钦,马丽,刘琳.慢性阻塞性肺疾病发病机制的研究进展[J].临床肺科杂志,2016,21(6):1113-1117.
[3]兰丰铃,王胜锋,曹卫华,等.慢性阻塞性肺疾病危险因素流行病学研究新进展[J].中华疾病控制杂志,2014,18(10):998-1002.
[4]胡大鹏,鲍文华,孙云晖,等.慢性阻塞性肺疾病易感基因研究进展[J].中国老年保健医学,2016,14(6):3-6.
[5]Singh S,Verma SK,Kumar S,et al.Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease[J].Scand J Immunol,2017,85(2):130-137.
[6]张笑天,郑晓瑛.氧化自由基清除剂超氧化物歧化酶与疾病[J].中国公共卫生,2014,30(10):1349-1352.
[7]Kobylecki CJ,Afzal S,Nordestgaard BG.Does SOD3 R213G Homozygosity Influence Morbidity,Mortality,and Lung Function in the General Population[J].Antioxidants&Redox Signaling,2016,24(15):884-891.
[8]Young RP,Hopkins R,Black PN,et al.Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function[J].Thorax,2006,61(5):394.
[9]Juul K,Tybjaerg-Hansen A,Marklund S,et al.Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2006,173(8):858-864.
[10]Korytina GF,Akhmadishina LZ,Cilousova OS,et al.Polymorphism of the genes for antioxidant defense enzymes and their association with the development of chronic obstructive pulmonary disease in the population of Bashkortostan[J].Genetika,2009,45(7):967.
[11]Mak JC,Ho SP,Yu WC,et al.Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD[J].European Respiratory Journal,2007,30(4):684.
[12]Siedlinski M,van Diemen CC,Postma DS,et al.Superoxide dismutases,lung function and bronchial responsiveness in a general population[J].European Respiratory Journal,2009,33(5):986.
[13]Houben JM,Mercken EM,Ketelslegers HB,et al.Telomere shortening in chronic obstructive pulmonary disease.[J].Respiratory Medicine,2009,103(2):230-236.
[14]Pietras T,Szemraj J,Witusik A,et al.The sequence polymorphism of MnSOD gene in subjects with respiratory insufficiency in COPD[J].Medical Science Monitor International Medical Journal of Experimental&Clinical Research,2010,6(9):CR427.
[15]韩轶群,薛玉文,李传芬,等.超氧化物岐化酶基因多态性与慢性阻塞性肺疾病易感性的关系[J].山东大学学报(医学版),2007(09):940-943.
[16]魏明霞,董坚,戴路明,等.细胞外超氧化物歧化酶肝素结合区基因多态性与慢性阻塞性肺疾病的关系[J].中华结核和呼吸杂志,2005(12):861-862.
[17]夏大庆,徐晓玲,夏淮玲,等.超氧化物歧化酶基因多态性与慢性阻塞性肺疾病的关系[J]. 中国慢性病预防与控制,2013(04):395-398.
[18]Kang SW.Superoxide dismutase 2 gene and cancer risk:evidence from an updated meta-analysis[J].Int J ClinExp Med,2015,8(9):14647-14655.
[19]Laukkanen MO.Extracellular Superoxide Dismutase:Growth Promoter or Tumor Suppressor[J].Oxidative Medicine and Cellular Longevity,2016,2016(22):1-9.
[20]Constantino L,Goncalves RC,Giombelli VR,et al.Regulation of lung oxidative damage by endogenous superoxide dismutase in sepsis[J].Intensive Care Med,2014,2(1):17.
[21]周倩倩,徐晓玲,夏大庆.戒烟对慢性阻塞性肺疾病肺功能的影响及机制探讨[J].安徽医科大学学报, 2014(09):1317-1320.
[22]林传钦,翟秀丽,邓托.中国人群慢性阻塞肺病相关危险因素的Meta分析[J].实用预防医学,2018(02):191-194.
[23]Fischer BM,Voynow JA,Ghio AJ.COPD:balancing oxidants and antioxidants[J].International Journal of Copd,2015,10(1):261-276.
相似文献/References:
[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(17):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(17):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(17):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(17):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及
炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(17):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病
引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(17):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并
重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(17):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(17):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[10]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及
MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(17):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]